Global Urinary Tract Infection Treatment Market 2017-2021

Publisher Name :
Date: 09-Aug-2017
No. of pages: 78
Price : Single User: US $ 3500  US $ 2500 Corporate User: US $ 5000  US $ 4000
Inquire Before Buying
Avail $1000 Discount on this report till 31 August 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

About Urinary Tract Infection Treatment

UTI is an infection occurred in any part of the urinary system. The infection mostly involves the lower part of the urinary tract. UTI can be classified into different types depending on the portion of the urinary system affected. Women are comparatively at a higher risk of developing UTI as compared with men since the urethra of the women is comparatively smaller than men and is also closer to the anus. This anatomical structure of the urinary tract in women increases the chances of transfer of the bacteria to the bladder. However, people of any sex and age can get affected by the disease.

The analysts forecast global urinary tract infection treatment market to grow at a CAGR of 2.15% during the period 2017-2021.

Covered in this report

This report covers the present scenario and the growth prospects of the global urinary tract infection treatment market for 2017-2021. To calculate the market size, the report considers the sales of branded, off-label, and generic drugs.

The market is divided into the following segments based on geography:

Americas

APAC

EMEA

This report, Global Urinary Tract Infection Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

Merck,

Bayer,

Johnson & Johnson,

Novartis

Other prominent vendors

Achaogen

Allergan

Aquinox Pharmaceuticals

AstraZeneca

Lipella Pharmaceuticals

MediciNova

MerLion Pharma

Mylan

Novo Nordisk

Shionogi

Sun Pharmaceuticals

Teva Pharmaceutical Industries

Urigen

Zavante Therapeutics

Market driver

Relation of UTI with several other factors leading to rising incidence rate of UTI

For a full, detailed list, view our report

Market challenge

Development of antibacterial resistance

For a full, detailed list, view our report

Market trend

Growing awareness of controlled usage of antibiotics

For a full, detailed list, view our report

Key questions answered in this report

What will the market size be in 2021 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

Avail $1000 Discount on this report till 31 August 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

Global Urinary Tract Infection Treatment Market 2017-2021

Table of Contents

PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
Market outline
PART 05: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 06: Pipeline analysis
PART 07: Market segmentation by disease type
Uncomplicated UTI
Complicated UTI
PART 08: Geographical segmentation
UTI treatment market in Americas
UTI treatment market in EMEA
UTI treatment market in APAC
PART 09: Decision framework
PART 10: Drivers and challenges
Market drivers
Market challenges
PART 11: Market trends
Growing awareness of controlled usage of antibiotics
Rising R&D for effective treatment against superbugs/MDR microorganisms
Advent of new therapies for UTI treatment
PART 12: Vendor landscape
PART 13: Key vendor analysis
Bayer
Johnson & Johnson
Merck
Novartis
Other prominent vendors
PART 14: Appendix
List of abbreviations

List of Exhibits
Exhibit 01: UTI in various parts of the urinary tract
Exhibit 02: Symptoms, diagnosis, and treatment of UTI
Exhibit 03: Common medications used for the treatment of UTI
Exhibit 04: Global UTI treatment market snapshot
Exhibit 05: Global UTI treatment market 2016-2021 ($ millions)
Exhibit 06: Opportunity analysis of global UTI treatment market
Exhibit 07: Five forces analysis
Exhibit 08: Key pipeline molecules by vendors
Exhibit 09: Global UTI treatment market: Key clinical trials
Exhibit 10: Segmentation of global UTI treatment market by disease type 2016
Exhibit 11: Causative organisms for uncomplicated UTI
Exhibit 12: Global uncomplicated UTI treatment market 2016-2021 ($ millions)
Exhibit 13: Risk factors for uncomplicated UTI
Exhibit 14: Management of uncomplicated UTI through antimicrobial agents
Exhibit 15: Causative organisms for complicated UTI
Exhibit 16: Global complicated UTI treatment market 2016-2021 ($ millions)
Exhibit 17: Risk factors for complicated UTI
Exhibit 18: Segmentation of global UTI treatment market based on geography 2016 and 2021
Exhibit 19: Global UTI treatment market revenue by geography 2016-2021 ($ millions)
Exhibit 20: Market scenario in Americas
Exhibit 21: UTI treatment market in Americas 2016-2021 ($ millions)
Exhibit 22: Market scenario in EMEA
Exhibit 23: UTI treatment market in EMEA 2016-2021 ($ millions)
Exhibit 24: Market scenario in APAC
Exhibit 25: UTI treatment market in APAC 2016-2021 ($ millions)
Exhibit 26: Major factors contributing to UTI
Exhibit 27: New cases of diabetes by 2040
Exhibit 28: Accepted indications for catheter use
Exhibit 29: Major causes of antibiotic resistance
Exhibit 30: Competitive structure analysis of global UTI treatment market 2016
Exhibit 31: Bayer: Key highlights
Exhibit 32: Bayer: Strength assessment
Exhibit 33: Bayer: Strategy assessment
Exhibit 34: Bayer: Opportunity assessment
Exhibit 35: Johnson & Johnson: Key highlights
Exhibit 36: Johnson & Johnson: Strength assessment
Exhibit 37: Johnson & Johnson: Strategy assessment
Exhibit 38: Johnson & Johnson: Opportunity assessment
Exhibit 39: Merck: Key highlights
Exhibit 40: Merck: Strength assessment
Exhibit 41: Merck: Strategy assessment
Exhibit 42: Merck: Opportunity assessment
Exhibit 43: Novartis: Key highlights
Exhibit 44: Novartis: Strength assessment
Exhibit 45: Novartis: Strategy assessment
Exhibit 46: Novartis: Opportunity assessment
  • Premature Ejaculation - Pipeline Insight, 2017
    Published: 28-Jul-2017        Price: US 1250 Onwards        Pages: 50
    DelveInsight's, "Premature Ejaculation-Pipeline Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Premature Ejaculation. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Premature Ejaculation by development stage, therapy type, route of administration and molecule type is also covered in the rep......
  • Pyelonephritis - Pipeline Insight, 2017
    Published: 28-Jul-2017        Price: US 1250 Onwards        Pages: 50
    DelveInsight's, "Pyelonephritis-Pipeline Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Pyelonephritis. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Pyelonephritis by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has a sp......
  • Premature Ejaculation - Epidemiology Insights to 2025
    Published: 28-Jul-2017        Price: US 2950 Onwards        Pages: 40
    DelveInsight's "Premature Ejaculation -Epidemiology Forecast, 2025" provides an overview of the epidemiology trends of Premature Ejaculation in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Premature Ejaculation. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the Premature Ejaculation. The report contains the targeted......
  • Premature Ejaculation - Market Insights, Epidemiology and Market Forecast - 2025
    Published: 28-Jul-2017        Price: US 5750 Onwards        Pages: 70
    DelveInsight's "Premature Ejaculation - Market Insights, Epidemiology and Market Forecast - 2025" report provides an overview of the disease and in depth research related to Premature Ejaculation for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Premature Ejaculation . It enables underst......
  • Pyelonephritis - Epidemiology Insights to 2025
    Published: 28-Jul-2017        Price: US 2950 Onwards        Pages: 40
    DelveInsight's "Pyelonephritis -Epidemiology Forecast, 2025" provides an overview of the epidemiology trends of Pyelonephritis in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Pyelonephritis. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the Pyelonephritis. The report contains the targeted patient populations and the......
  • Pyelonephritis - Market Insights, Epidemiology and Market Forecast - 2025
    Published: 28-Jul-2017        Price: US 5750 Onwards        Pages: 70
    DelveInsight's "Pyelonephritis - Market Insights, Epidemiology and Market Forecast - 2025" report provides an overview of the disease and in depth research related to Pyelonephritis for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Pyelonephritis . It enables understanding of the histori......
  • Urinary Incontinence - Pipeline Review, H2 2017
    Published: 11-Jul-2017        Price: US 2000 Onwards        Pages: 69
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Urinary Incontinence - Pipeline Review, H2 2017, provides an overview of the Urinary Incontinence (Genito Urinary System And Sex Hormones) pipeline landscape.Urinary incontinence is a loss of control of the bladder. In some cases, it may result in a total loss of the bladder's contents or it may just cause minor leakage. Symptoms include stress incontinence, rashes and other skin disorders. Risk factors includ......
  • Interstitial Cystitis - Epidemiology Insights to 2025
    Published: 05-Jul-2017        Price: US 2950 Onwards        Pages: 40
    DelveInsight " Interstitial Cystitis - Epidemiology Forecast To 2025" provides an overview of the epidemiology trends of Interstitial Cystitis in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Interstitial Cystitis prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need assoc......
  • Urinary Incontinence - Epidemiology Insights to 2025
    Published: 05-Jul-2017        Price: US 2950 Onwards        Pages: 40
    DelveInsight " Urinary Incontinence - Epidemiology Forecast To 2025" provides an overview of the epidemiology trends of Urinary Incontinence in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Urinary Incontinence prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associat......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs